Previous 10 | Next 10 |
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”) a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it intends t...
Ondas Holdings (ONDS) -17% after securing $44.8M capital via equity raise.CEL-SCI (CVM) -12% after securing $31.7M capital raise.UiPath (PATH) -10% on Q1 earnings release.United Natural Foods (UNFI) -9% on FQ3 earnings release.Eastman Kodak (KODK) -10%....
Photo by smirart/iStock via Getty Images Second Sight Medical Products (EYES) has filed for a prospectus to issue $250M worth of securities in a mixed shelf offering. The company shares have lost ~3.6% in the pre-market. Second Sight Medical have more than tripled in value so f...
Second Sight Medical Products (EYES) has found a market niche for itself in the healthcare space developing implantable visual prosthetics to treat sight-impaired people. With the U.S. FDA approval for its Argus 2s Retinal Prosthesis System in hand, can the stock keep soaring in the coming mo...
Second Sight Medical ([[EYES]] +23.0%) is soaring in morning hours despite a lawsuit filed against the company in France.In a regulatory filing, the company disclosed that on June 01, it received a summons from Pixium Vision in connection with a lawsuit filed in the Commercial Court...
Gainers: Washington Prime (WPG) +99%.Orbital Energy (OEG) +67%.Vertex Energy (VTNR) +28%.LexinFintech (LX) +28%.ENGlobal (ENG) +28%.New Concept Energy (GBR) +26%.Cloudera (CLDR) +24%.Aethlon Medical (AEMD) +24%.Aesthetic Medical International (AIH) +22%.Lineage Cell Therapeutics (LCTX) +...
Gainers: Nuwellis (NUWE) +20%, Aesthetic Medical International (AIH) +20%, Aethlon Medical (AEMD) +19%, Lineage Cell Therapeutics LCTX +18%, Rezolute (RZLT) +17%.Losers: Immunovant IMVT -27%, Shineco (TYHT) -12%, Genetic Technol...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its a...
Reddit Biotech Penny Stocks Remain in Focus in June 2021 Finding penny stocks on Reddit has become a major strategy for all types of investors. While Reddit hasn’t always been the place to find and make a penny stocks watchlist , it is more popular than ever. While there are ...
Second Sight Medical Products ([[EYES]] +6.9%) is trading higher on the news of a patent granted to the company by the European Patent Office ((EPO)).The patent titled “Cortical interface with an electrode array divided into separate fingers and/or with a wireless transceiver” h...
News, Short Squeeze, Breakout and More Instantly...
Second Sight Medical Products Inc. Company Name:
EYES Stock Symbol:
NASDAQ Market:
Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...
Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...